Valeo Pharma Earnings inline, Revenue beats In Q3

  • Investing.com
Valeo Pharma Earnings inline, Revenue beats In Q3

Investing.com - Valeo (EPA: VLOF ) Pharma reported on Tuesday third quarter earnings that matched analysts' forecasts and revenue that topped expectations.

Valeo Pharma announced earnings per share of C$-0.055 on revenue of C$6.1M. Analysts polled by Investing.com anticipated EPS of C$-0.055 on revenue of C$6M.

Valeo Pharma shares are down 23.13% from the beginning of the year and are trading at C$0.58 , down-from-52-week-high.

Valeo Pharma follows other major Healthcare sector earnings this month

Valeo Pharma's report follows an earnings missed by Cresco Labs on Wednesday, August 17, 2022, who reported EPS of C$-0.02 on revenue of C$218.23M, compared to forecasts EPS of C$-0.0161 on revenue of C$218.27M.

Jushi Holdings had missed expectations on Monday, August 29, 2022 with second quarter EPS of C$-0.15 on revenue of C$72.8M, compared to forecast for EPS of C$-0.0932 on revenue of C$69.15M.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100